Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients (Q33220572)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients
scientific article

    Statements

    Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients (English)
    5088-5093

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit